Curaleaf reported a larger-than-expected quarterly loss, though its recent earnings and business updates paint a mixed picture.
Curaleaf Holdings Inc. (TSX: CURA) reported adjusted earnings per share of -US$0.1729 for the quarter ended September 30, 2026, compared with an estimated loss of US$0.15. That’s a 15.3% miss. The result follows two quarters of positive reported EPS and one smaller loss. Before this quarter, Curaleaf had beaten estimates in three of the previous four comparable quarters. The company did not provide revenue or margin details for the quarter, so it’s unclear what drove the miss. For Canadian investors, the result comes as Curaleaf faces a contested bid for Aurora Cannabis and has recently reported higher revenue and improved profitability.
Recent earnings trend
Curaleaf Holdings Inc.
CURA.TO
CURA.TO
Curaleaf Holdings Inc.
WealthAwesomeMarket cap
$3.55B
52W high
$20.93
52W low
$7.77
1W change
+12.51%
Beta
1.76
Analyst Price Targets
Based on analyst covering CURA · as of Nov 5, 2026
Wall Street analysts forecast CURA stock price to rise 34.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$18.08
+34.9% Upside
Previously C$18.10 on Nov 4, 2026
Current Price
C$13.40
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CURA's historical volatility
30-Day Vol
65.4%
Annualized
90-Day Vol
61.7%
Annualized
Trend (90d)
+10.2%
Annualized drift
90d Mean
C$13.89
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$13.56 | C$10.82 – C$17.00 |
| 60 trading days | C$13.73 | C$9.98 – C$18.89 |
| 90 trading days | C$13.89 | C$9.40 – C$20.54 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 1 analyst(s) cover this name; upcoming EPS consensus is available.
Beat estimates in 3 of the last 4 comparable quarter(s).
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-09-30 | 2026-11-03 | -0.1729 | -0.1500 | -15.3% |
| 2026-06-30 | 2026-08-05 | 0.0700 | -0.2400 | +129.2% |
| 2026-03-31 | 2026-05-04 | 0.2900 | -0.2700 | +207.4% |
| 2025-12-31 | 2026-02-26 | -0.0500 | -0.0900 | +44.4% |
| 2025-09-30 | 2025-11-04 | -0.1900 | -0.2400 | +20.8% |
| 2025-06-30 | 2025-08-06 | -0.1900 | -0.2100 | +9.5% |
Investor takeaway: The EPS miss is a setback, but the available figures don’t show whether it came from operations, costs, or other factors. Weigh the result against Curaleaf’s recent EPS record, its negative trailing EPS and profit margin, and the risks tied to its business and Aurora bid. Analyst targets and statistical forecasts are reference points, not guarantees.
US$0.1729 loss per share
Curaleaf’s reported EPS was US$0.0229 worse than the estimated loss of US$0.15, a 15.3% negative surprise. The company had beaten estimates in three of the previous four comparable quarters.
Bull case
Curaleaf beat EPS estimates in three of the last four comparable quarters, including reporting positive EPS in March and June 2026. Recent company news also pointed to higher revenue and improved profitability. Earlier updates described growth in international markets and a recovery in domestic operations. The average analyst target of C$18.08 is above the last close of C$13.40, but that comparison is not a formal rating for the Canadian listing.
Bear case
Curaleaf’s latest EPS loss was wider than expected, and the company remains unprofitable based on the supplied trailing figures: EPS (TTM) of -0.07 and a profit margin of -2.63%. Earlier updates flagged pricing pressure and rising operating expenses. The proposed Aurora acquisition also adds uncertainty. The share price is well below its 52-week high, and the statistical forecast’s wide ranges point to substantial uncertainty.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
